摘要 |
<p>The expression of ubiquitin carboxy-terminal hydrolase is aberrant in cells that are resistant to treatment with chemical agents. Accordingly, the invention features methods for diagnosing and treating drug resistant cells (e.g., tumor cells) by examining and modulating the expression or activity of UCH.</p> |